Ophthotech, Novartis in Fovista Drug Pact

Swiss drug maker Novartis said it has entered into an exclusive agreement with Ophthotech. to commercialize the biopharmaceutical company's wet age-related macular degeneration treatment Fovista outside the U.S.



from WSJ.com: US Business http://ift.tt/1j43RlJ

via IFTTT